NYSE$CYH
Community Health Systems Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Community Health Systems' financial performance improved with increased revenues and a reduced net loss, driven by same-store volume growth and effective expense management.
Community Health Systems reported a net operating revenue of $3.140 billion for Q2 2024, a 0.8% increase compared to the same period in 2023. The net loss attributable to stockholders was $(13) million, or $(0.10) per share, an improvement from $(38) million, or $(0.29) per share, in Q2 2023. Adjusted EBITDA increased to $387 million from $373 million year-over-year.
- Net operating revenues increased to $3.140 billion.
- Net loss attributable to stockholders improved to $(13) million, or $(0.10) per share.
- Adjusted EBITDA rose to $387 million.
- Same-store admissions increased by 3.0 percent and adjusted admissions increased 3.2 percent.
Headline financials
Revenue & EPS history
CHS · Revenue · Quarterly
$3.14B
Forward guidance
Community Health Systems projects net operating revenues between $12.5 billion and $12.7 billion and Adjusted EBITDA between $1.52 billion and $1.60 billion for the year ending December 31, 2024. They anticipate a net loss per share between $(0.45) and $(0.30).
Tailwinds
- Net operating revenues are projected between $12.5 billion and $12.7 billion.
- Adjusted EBITDA is expected to be between $1.52 billion and $1.60 billion.
- Depreciation and amortization are estimated at approximately 4.0% of net operating revenues.
- Net income attributable to noncontrolling interests is projected at 1.2% to 1.3% of net operating revenues.
- Capital expenditures are projected between $350 million and $400 million.
Headwinds
- Net loss per share - diluted is projected between $(0.45) and $(0.30).
- Interest expense is estimated to be between $850 million and $865 million.
- Provision for income taxes is projected at 0.9% to 1.0% of net operating revenues.
- Net cash provided by operating activities is projected between $500 million and $650 million.
- Exclusion of gains/losses from debt refinancing, asset impairments, divestitures, and legal settlements.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
+1.7%
Avg return
Earnings day
+3.6%
Avg return
5 days after
+2.4%
Avg return
30 days after
55%
38 / 69 earnings
Positive
+52.4%
Q4 2022
Best reaction
-41.0%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -3.3% | +6.3% | +3.0% | |
| Q4 2025 | +5.7% | +4.5% | -13.5% | |
| Q3 2025 | +25.8% | +29.1% | -4.3% | |
| Q2 2025 | +0.0% | -0.7% | +7.7% | |
| Q1 2025 | +18.5% | +11.1% | +51.0% | |
| Q4 2024 | +7.8% | +9.9% | -22.4% | |
| Q3 2024 | -22.6% | -25.3% | -33.5% | |
| Q2 2024 | +17.5% | +27.9% | +24.9% | |
| Q1 2024 | +9.8% | +11.1% | +20.9% | |
| Q4 2023 | -28.4% | -27.7% | -11.6% | |
| Q3 2023 | -7.0% | -18.0% | +12.1% | |
| Q2 2023 | +11.8% | -8.4% | -18.9% | |
| Q1 2023 | -39.9% | -42.3% | -48.4% | |
| Q4 2022 | +52.4% | +56.3% | -0.6% | |
| Q3 2022 | +36.8% | +35.4% | +68.9% | |
| Q2 2022 | -41.0% | -39.6% | -38.6% | |
| Q1 2022 | -4.2% | -19.1% | -40.1% | |
| Q4 2021 | -10.1% | -21.3% | -15.1% | |
| Q3 2021 | +19.1% | +28.9% | +28.4% | |
| Q2 2021 | -6.4% | -8.3% | -13.1% | |
| Q1 2021 | +0.3% | +15.2% | +37.9% | |
| Q4 2020 | -7.6% | -9.3% | +28.3% | |
| Q3 2020 | +19.2% | +30.3% | +78.3% | |
| Q2 2020 | +14.2% | +26.4% | +37.8% | |
| Q1 2020 | -7.4% | -22.9% | -11.8% | |
| Q4 2019 | +42.7% | +27.8% | -44.2% | |
| Q3 2019 | -17.0% | -30.4% | -32.6% | |
| Q2 2019 | +12.9% | +25.8% | +39.7% | |
| Q1 2019 | -1.7% | -4.0% | -19.9% | |
| Q4 2018 | +12.8% | +21.4% | +8.5% | |
| Q3 2018 | -6.3% | +20.0% | +33.3% | |
| Q2 2018 | +2.3% | +9.5% | +16.7% | |
| Q1 2018 | +34.7% | +26.5% | +8.2% | |
| Q4 2017 | -11.6% | -15.0% | -31.6% | |
| Q3 2017 | -23.1% | -26.6% | -26.3% | |
| Q2 2017 | -7.8% | -8.8% | +6.9% | |
| Q1 2017 | +19.9% | +11.7% | +2.8% | |
| Q4 2016 | +33.8% | +33.6% | +21.7% | |
| Q3 2016 | +0.8% | +4.9% | +3.0% | |
| Q2 2016 | -1.5% | -0.5% | -19.3% | |
| Q1 2016 | -22.1% | — | — | |
| Q4 2015 | -22.1% | — | — | |
| Q3 2015 | -2.4% | — | — | |
| Q2 2015 | +1.2% | — | — | |
| Q1 2015 | -7.6% | — | — | |
| Q4 2014 | +1.2% | — | — | |
| Q3 2014 | -5.0% | — | — | |
| Q2 2014 | -4.9% | — | — | |
| Q1 2014 | -7.2% | — | — | |
| Q4 2013 | +0.3% | — | — | |
| Q3 2013 | -0.3% | — | — | |
| Q2 2013 | +2.2% | — | — | |
| Q1 2013 | +4.7% | — | — | |
| Q4 2012 | +1.4% | — | — | |
| Q3 2012 | +2.4% | — | — | |
| Q2 2012 | -4.3% | — | — | |
| Q1 2012 | +5.2% | — | — | |
| Q4 2011 | +5.3% | — | — | |
| Q3 2011 | -2.7% | — | — | |
| Q2 2011 | -6.4% | — | — | |
| Q1 2010 | -3.5% | — | — | |
| Q1 2011 | +0.1% | — | — | |
| Q4 2008 | +8.0% | — | — | |
| Q4 2010 | +8.0% | — | — | |
| Q3 2009 | +2.0% | — | — | |
| Q3 2010 | +2.0% | — | — | |
| Q4 2009 | +4.3% | — | — | |
| Q2 2009 | +4.3% | — | — | |
| Q2 2010 | +4.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro